Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy Coiffier B; Pro B; Prince HM; Foss F; Sokol L; Greenwood M; María Dolores Caballero Barrigón; Borchmann P; Morschhauser F; Wilhelm M; Pinter-Brown L; Padmanabhan S; Shustov A; Nichols J; Carroll S; Balser J; Balser B; Horwitz S Journal Of Clinical Oncology ; 30, pp. 631 - 636 Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation Sureda A; Canals C; Arranz R; María Dolores Caballero Barrigón; Ribera JM; Brune M; Passweg J; Martino R; Valcárcel D; Besalduch J; Duarte R; León A; Pascual MJ; García-Noblejas A; Lucía López Corral; Xicoy B; Sierra J; Schmitz N Haematologica-The Hematology Journal ; 97, pp. 310 - 317 High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma Bruno David Lourenço Paiva; Norma Carmen Gutiérrez Gutiérrez; Laura Rosinol; María Belén Vidriales Vicente; Maria-Angeles Montalban; Joaquin Martinez-Lopez; María Victoria Mateos Manteca; Maria-Teresa Cibeira; Lourdes Cordon; Albert Oriol; Maria-Jose Terol; Maria-Asuncion Echeveste; Raquel de Paz; Felipe de Arriba; Luis Palomera; Javier de la Rubia; Joaquin Diaz-Mediavilla; Anna Sureda; Ana Gorosquieta; Adrian Alegre; Alejandro Martín García Sancho; Miguel T. Hernandez; Juan-Jose Lahuerta; Joan Blade; Jesús Fernando San Miguel Izquierdo; PETHEMA Cooperativa Study Grp; GEM Cooperativa Study Grp Blood ; 119, pp. 687 - 691 Update on the role of autologous hematopoietic stem cell transplantation in follicular lymphoma. Cabrero M; Redondo A; Alejandro Martín García Sancho; María Dolores Caballero Barrigón Mediterranean Journal Of Hematology And Infectious Diseases ; 4 Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too Canales MA, Martín A, Caballero D, Hernández-Navarro F. British Journal of Haematology 134(6):645-6. FI: 4.597 (Q1) Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients Penalver FJ, Jimenez-Yuste V, Almagro M, Olivarez-Larrán A, Rodriguez L, Cased M, Gallur L, Giraldo P, Hernández R, Manor D, Rodriguez MJ, Caballero D, Gonzalez R, Mayans J, Milan I, Cabrera JR, On behalf of the Multi-institutional Retrospective Spanish Study on the use of rituximab in refractory ITP. Annals of Hematology 85(6):400-6. FI: 2.919 (Q2) Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation Martino R, Parody R, Fukuda T, Maertens J, Theunissen K, Ho A, Mufti GJ, Kroger N, Zander AR, Heim D, Paluszewska M, Selleslag D, Steinerova K, Ljungman P, Cesaro S, Nihtinen A, Cordonnier C, Vázquez L, López-Duarte M, Lopez J, Cabrera R, Rovira M, Neuburger S, Cornely O, Hunter AE, Marr KA, Dornbusch HJ, Einsele H. Blood 108(9):2928-36. FI: 10.555 (Q1) Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines Blanco B, Pérez-Simón JA, Sánchez-Abarca LI, Carvajal-Vergara X, Mateos J, Vidriales B, López-Holgado N, Maiso P, Alberca M, Villarón E, Schenkein D, Pandiella A, San Miguel JF. Blood 107(9):3575-83. FI: 10.555 (Q1) Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD) Castilla C, Pérez-Simón JA, Sánchez-Guijo FM, Díez-Campelo M, Ocio E, Pérez-Persona E, López-Villar O, Vázquez L, Caballero D, San Miguel JF. Biology of Blood and Marrow 12(9):936-41. FI: 3.149 (Q2) Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy Mateos J, Pérez-Simón JA, Caballero D, Castilla C, López O, Pérez E, Cañizo C, Vázquez L, San Miguel JF. Bone Marrow Trasplantation 37(3):337-8. FI: 2.998 (Q3)
101 resultados
Páginas: < 1 2 3 4 5 > >>
|
